Market Closed -
Singapore S.E.
06:41:12 11/04/2024 am IST
|
5-day change
|
1st Jan Change
|
0.038
SGD
|
-.--%
|
|
-.--%
|
-38.71%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
442.8
|
359.2
|
358.2
|
575.3
|
393.5
|
170.6
|
Enterprise Value (EV)
1 |
393.3
|
380.7
|
377.1
|
604.6
|
389.4
|
144.9
|
P/E ratio
|
-967
x
|
-26.6
x
|
-29.6
x
|
-62.2
x
|
-5.81
x
|
-3.61
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.72
x
|
2.55
x
|
2.68
x
|
3.59
x
|
2.81
x
|
0.96
x
|
EV / Revenue
|
3.3
x
|
2.7
x
|
2.82
x
|
3.77
x
|
2.78
x
|
0.81
x
|
EV / EBITDA
|
42.9
x
|
138
x
|
69.9
x
|
206
x
|
-421
x
|
9.5
x
|
EV / FCF
|
-7.37
x
|
67.2
x
|
79
x
|
-20.4
x
|
11.1
x
|
11.9
x
|
FCF Yield
|
-13.6%
|
1.49%
|
1.27%
|
-4.9%
|
8.99%
|
8.39%
|
Price to Book
|
1.8
x
|
1.53
x
|
1.6
x
|
1.58
x
|
1.27
x
|
0.64
x
|
Nbr of stocks (in thousands)
|
3,81,575
|
3,81,575
|
3,81,575
|
5,08,848
|
5,11,289
|
5,11,289
|
Reference price
2 |
1.160
|
0.9415
|
0.9387
|
1.131
|
0.7697
|
0.3336
|
Announcement Date
|
12/04/19
|
11/06/20
|
12/04/21
|
12/04/22
|
11/04/23
|
08/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
119.1
|
141.1
|
133.6
|
160.4
|
140.3
|
178.2
|
EBITDA
1 |
9.161
|
2.764
|
5.394
|
2.939
|
-0.925
|
15.26
|
EBIT
1 |
0.949
|
-7.659
|
-5.531
|
-7.568
|
-11.82
|
4.576
|
Operating Margin
|
0.8%
|
-5.43%
|
-4.14%
|
-4.72%
|
-8.43%
|
2.57%
|
Earnings before Tax (EBT)
1 |
0.399
|
-11.34
|
-11.89
|
-6.834
|
-72.96
|
-44.14
|
Net income
1 |
-0.453
|
-13.52
|
-12.1
|
-7.326
|
-67.67
|
-47.3
|
Net margin
|
-0.38%
|
-9.58%
|
-9.06%
|
-4.57%
|
-48.25%
|
-26.54%
|
EPS
2 |
-0.001200
|
-0.0354
|
-0.0317
|
-0.0182
|
-0.1325
|
-0.0925
|
Free Cash Flow
1 |
-53.33
|
5.664
|
4.776
|
-29.62
|
35.01
|
12.15
|
FCF margin
|
-44.77%
|
4.01%
|
3.58%
|
-18.47%
|
24.96%
|
6.82%
|
FCF Conversion (EBITDA)
|
-
|
204.92%
|
88.55%
|
-
|
-
|
79.66%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/04/19
|
11/06/20
|
12/04/21
|
12/04/22
|
11/04/23
|
08/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
21.5
|
19
|
29.3
|
-
|
-
|
Net Cash position
1 |
49.5
|
-
|
-
|
-
|
4.16
|
25.6
|
Leverage (Debt/EBITDA)
|
-
|
7.766
x
|
3.515
x
|
9.952
x
|
-
|
-
|
Free Cash Flow
1 |
-53.3
|
5.66
|
4.78
|
-29.6
|
35
|
12.2
|
ROE (net income / shareholders' equity)
|
-0.19%
|
-5.63%
|
-5.29%
|
-2.5%
|
-20.1%
|
-16.4%
|
ROA (Net income/ Total Assets)
|
0.22%
|
-1.67%
|
-1.13%
|
-1.27%
|
-1.82%
|
0.83%
|
Assets
1 |
-204
|
811
|
1,073
|
576.7
|
3,711
|
-5,677
|
Book Value Per Share
2 |
0.6400
|
0.6100
|
0.5900
|
0.7200
|
0.6100
|
0.5200
|
Cash Flow per Share
2 |
0.1300
|
0.0700
|
0.1000
|
0.0500
|
0.0800
|
0.1000
|
Capex
1 |
33.9
|
15.3
|
3.13
|
6.37
|
3.95
|
3.84
|
Capex / Sales
|
28.45%
|
10.86%
|
2.34%
|
3.97%
|
2.82%
|
2.16%
|
Announcement Date
|
12/04/19
|
11/06/20
|
12/04/21
|
12/04/22
|
11/04/23
|
08/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -38.71% | 14.31M | | +14.10% | 81.68B | | -30.15% | 69.23B | | +9.37% | 29.08B | | -11.90% | 16.88B | | +0.32% | 16.85B | | -1.12% | 15.15B | | +6.06% | 12.62B | | +35.78% | 12.47B | | -3.02% | 11.66B |
Other Healthcare Facilities & Services
|